8-K: MetLife's Q2 2025 Earnings Decline Amid Investment Headwinds

MetLife reports a 16% drop in adjusted earnings for Q2 2025, primarily due to less favorable underwriting and lower investment margins, despite strong volume growth in international segments.

Summary

• Net income decreased by 23% to $698 million, or $1.03 per share, in Q2 2025 compared to $912 million, or $1.28 per share, in Q2 2024.
• Adjusted earnings fell 16% to $1,362 million ($2.02 per share) in Q2 2025 from $1,628 million ($2.28 per share) in Q2 2024, a 15% decline on a constant currency basis.
• Adjusted premiums, fees, and other revenues (PFOs), excluding pension risk transfers (PRT), increased 5% to $12.4 billion.
• Net investment income rose 9% to $5.7 billion, while adjusted net investment income increased 1% to $5.2 billion.
• Variable investment income (VII) decreased 35% to $195 million, falling below the quarterly target of $425 million due to lower private equity returns.
• Book value per share (BVPS) increased 7% to $35.79, and adjusted BVPS rose 6% to $56.23.
• Return on Equity (ROE) was 11.7%, and Adjusted ROE was 14.6%.
• The direct expense ratio, excluding notable items and PRT, improved to 11.7%, below the 12.1% annual target.
• Holding company cash and liquid assets totaled $5.2 billion at quarter-end.
• Total cash returned to shareholders was $892 million in Q2 2025, including $510 million in share repurchases and $382 million in common stock dividends.
• Year-to-date share repurchases totaled approximately $2.1 billion, with about $140 million in July 2025.
• Expected U.S. Statutory Adjusted Capital on an NAIC basis was $17.1 billion at June 30, 2025, a 3% decrease from $17.6 billion at March 31, 2025.
• The expected Japan Solvency Margin ratio was approximately 710% at June 30, 2025.
• Institutional client assets under management at MetLife Investment Management grew to over $200 billion.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to significant declines in net income and adjusted earnings, primarily driven by lower variable investment income and less favorable underwriting. While there are positives like expense management and growth in some international segments, the core profitability metrics show a notable downturn compared to the prior year and against internal targets for investment income.

Positives

• Adjusted premiums, fees, and other revenues (PFOs), excluding pension risk transfers (PRT), increased 5% to $12.4 billion, indicating underlying business growth.
• Net investment income rose 9% to $5.7 billion, primarily due to increases in the estimated fair value of certain securities.
• Book value per share (BVPS) increased 7% to $35.79, and adjusted BVPS rose 6% to $56.23, reflecting balance sheet strength.
• The direct expense ratio, excluding notable items and PRT, improved to 11.7%, falling below the 12.1% annual target, demonstrating effective expense management.
• Holding company cash and liquid assets increased to $5.2 billion, providing strong liquidity.
• The company returned approximately $900 million to shareholders in Q2 2025 through share repurchases ($510 million) and common stock dividends ($382 million), indicating commitment to shareholder returns.
• Latin America adjusted earnings increased 15% on a constant currency basis, driven by volume growth and favorable Chilean encaje returns.
• EMEA adjusted earnings rose 30% on a constant currency basis, reflecting strong volume growth across the region.
• Asia sales increased 9% on a constant currency basis, led by strong performance in Japan and Korea.
• Total liability exposure in Retirement and Income Solutions (RIS) grew 6%, including 5% in general account liabilities, indicating business expansion.
• Institutional client assets under management at MetLife Investment Management grew to over $200 billion.

Negatives

• Net income decreased 23% to $698 million, primarily driven by higher net derivative losses and lower adjusted earnings.
• Adjusted earnings declined 16% to $1,362 million, mainly due to less favorable underwriting and lower investment margins.
• Variable investment income (VII) decreased 35% to $195 million, falling significantly below the quarterly target of $425 million due to lower private equity returns.
• Group Benefits adjusted earnings decreased 25% due to less favorable underwriting across life and non-medical health products.
• Retirement and Income Solutions (RIS) adjusted earnings declined 10%, largely due to less favorable recurring interest margins.
• Asia adjusted earnings decreased 22% on both reported and constant currency bases, driven by less favorable investment and underwriting margins.
• MetLife Holdings adjusted earnings decreased 6%, reflecting lower variable investment income and the continued run-off of the business.
• Corporate & Other segment reported an adjusted loss of $233 million, compared to a loss of $220 million in the prior year period.
• Net derivative losses amounted to $796 million, or $629 million after tax, driven by stronger equity markets and higher long-term interest rates.

Risks

• Economic condition difficulties, including risks relating to interest rates, tariffs, credit spreads, declining equity or debt markets, real estate, obligors and counterparties, government default, currency exchange rates, derivatives, climate change, public health and terrorism and security.
• Global capital and credit market adversity.
• Credit facility inaccessibility.
• Financial strength or credit ratings downgrades.
• Unavailability, unaffordability, or inadequate reinsurance, including reinsurance risks that arise from reinsurers' credit risk, and the potential shortfall or failure of risk mitigants to protect against such risks.
• Statutory life insurance reserve financing costs or limited market capacity.
• Legal, regulatory, and supervisory and enforcement policy changes.
• Changes in tax rates, tax laws or interpretations.
• Litigation and regulatory investigations.
• Unsuccessful efforts to meet all environmental, social, and governance standards or to enhance sustainability.
• Inability to pay dividends and repurchase common stock.
• Subsidiaries' inability to pay dividends to MetLife, Inc.
• Investment defaults, downgrades, or volatility.
• Investment sales or lending difficulties.
• Collateral or derivative-related payments.
• Investment valuations, allowances, or impairments changes.
• Claims or other results that differ from estimates, assumptions, or models.
• Global political, legal, or operational risks.
• Business competition.
• Technological changes.
• Catastrophes.
• Climate changes or responses to it.
• Deficiencies in the closed block.
• Goodwill or other asset impairment, or deferred income tax asset allowance.
• Impairment of VOBA, value of distribution agreements acquired or value of customer relationships acquired.
• Product guarantee volatility, costs, and counterparty risks.
• Risk management failures.
• Insufficient protection from operational risks.
• Failure to protect confidentiality, integrity or availability of systems or data or other cybersecurity or disaster recovery failures.
• Accounting standards changes.
• Excessive risk-taking.
• Marketing and distribution difficulties.
• Pension and other postretirement benefit assumption changes.
• Inability to protect intellectual property or avoid infringement claims.
• Acquisition, integration, growth, disposition, or reorganization difficulties.
• Brighthouse Financial, Inc. separation risks.
• MetLife, Inc.'s Board of Directors influence over the outcome of stockholder votes through the voting provisions of the MetLife Policyholder Trust.
• Legaland corporate governance-related effects on business combinations.

Future Outlook

The company is confident in the resiliency and 'all-weather' nature of its 'New Frontier' strategy and its ability to deliver on commitments. It continues to progress on strategic transactions with Chariot Re, Talcott Financial Group, and PineBridge Investments to accelerate growth in asset management and capitalize on its retirement platform.

Management Comments

• "This quarter, we continued to execute our New Frontier strategy to create value for our customers and shareholders."
• "While the quarter didn't demonstrate the full earnings power of MetLife, we saw clear momentum across several of our market-leading businesses, coupled with solid underlying fundamentals."
• "Higher sales drove revenue growth in Asia, Latin America and EMEA as we leveraged our leading positions in international markets."
• "We continued to progress on our previously announced strategic transactions with Chariot Re, Talcott Financial Group and PineBridge Investments to accelerate our growth in asset management and capitalize on our retirement platform."
• "And we diligently managed expenses while returning capital to shareholders."
• "Looking ahead, we're confident in the resiliency and all-weather nature of our New Frontier strategy and our ability to deliver on our commitments."

Industry Context

The results reflect a mixed environment for global insurers. While some international segments like Latin America and EMEA show strong volume growth, indicating robust demand in those markets, the overall adjusted earnings were impacted by less favorable underwriting and lower investment margins, particularly from private equity. This suggests that while core insurance operations are performing well in certain regions, the broader investment landscape, characterized by market volatility and specific asset class performance (like private equity), continues to influence profitability. The focus on expense management and strategic transactions in asset management aligns with broader industry trends of optimizing operational efficiency and diversifying revenue streams beyond traditional insurance products.

Comparison to Industry Standards

• The decline in variable investment income due to lower private equity returns is a common challenge faced by many insurers and asset managers with significant private equity allocations in the current market cycle. Companies like Prudential Financial or Aflac, which also have substantial investment portfolios, could experience similar pressures if their private asset valuations are impacted.
• The improvement in the direct expense ratio to 11.7% (below the 12.1% annual target) indicates strong cost control, which is a positive differentiator in a competitive insurance market. This efficiency could compare favorably to peers still struggling with higher operational costs.
• The 6% growth in total liability exposures for Retirement and Income Solutions, including 5% in general account liabilities, suggests a healthy demand for retirement products, potentially outperforming some competitors in a rising interest rate environment where fixed income products become more attractive.
• The 9% constant currency sales growth in Asia, particularly in Japan and Korea, highlights MetLife's strong market position and effective distribution in key Asian markets, potentially outpacing regional competitors in those specific geographies.
• The 15% constant currency adjusted earnings growth in Latin America demonstrates robust performance in emerging markets, which can be a significant growth driver compared to more mature markets for global insurers.

Stakeholder Impact

• Shareholders: Experience lower earnings per share but benefit from significant capital returns through share repurchases and common stock dividends.
• Customers: Benefit from the continued execution of the 'New Frontier' strategy and volume growth in various segments, implying ongoing service and product availability.
• Employees: No direct impact on employment or compensation explicitly mentioned, but overall company performance can indirectly affect employee morale and future opportunities.
• Creditors: The company's strong holding company cash position and expected capital levels suggest continued financial stability, which is positive for creditors.

Next Steps

• MetLife will hold its second quarter 2025 earnings conference call and audio webcast on Thursday, August 7, 2025, from 9-10 a.m. (ET).

Key Dates

Recommendation

While MetLife's Q2 2025 adjusted earnings and net income declined significantly, primarily due to lower variable investment income and less favorable underwriting, the company demonstrates resilience through strong expense management, robust capital returns to shareholders, and volume growth in key international markets (Latin America, EMEA, Asia). The 'New Frontier' strategy, including strategic transactions in asset management, indicates a clear path for future value creation. The diversified business model and solid capital position provide a buffer against current headwinds. Given the mixed results, with some segments showing strength despite overall earnings pressure, a 'hold' recommendation is appropriate as the company navigates a challenging investment environment while executing its long-term strategy.

Keywords

MetLife, Insurance, Financial Services, Earnings Report, Q2 2025, Adjusted Earnings, Net Income, Variable Investment Income, Share Repurchases, Dividends, Asset Management, SEC Filing, MET, Life Insurance, Retirement Solutions, Global Markets